Do beta-blockers worsen respiratory status in patients with COPD?
Metadata[+] Show full item record
Do beta-blockers worsen respiratory status in patients with COPD? Evidence-Based Answer: Use of beta-blockers in patients with mild to moderate chronic obstructive pulmonary disease (COPD) does not adversely affect forced expiratory volume in 1 second (FEV1), symptoms, or beta-agonist response (SOR: A, meta-analysis). The effect on mortality is mixed. In COPD populations with high prevalence of heart failure and vascular disease, beta-blockers (predominantly noncardioselective beta-blockers) are associated with decreased mortality (SOR: B, systematic review of cohort studies and single cohort study). In patients with more severe, oxygen-dependent COPD, beta-blockers may be associated with increased mortality (SOR: C, cohort study).
Evidence-based practice 18, no. 08 (2015): E1-E2